Research output: Contribution to journal › Article › peer-review
Novel non-covalent conjugate based on graphene oxide and alkylating agent from 1,3,5-triazine class. / Sharoyko, Vladimir V. ; Semenov, Konstantin N. ; Mikolaichuk, Olga V.; Shemchuk, Olga S. ; Abdelhali, Abdelsattar O. E. ; Potanin, Artem A. ; Luttsev, Michail D. ; Daler R. Dadajanov; Shasherina, Anna Yu. ; Petrov, Andrey V. ; Murin, Igor V. ; Maystrenko, Dmitriy N.; Molchanov, Oleg E. ; Vartanyan, T.A.
In: Journal of Molecular Liquids, Vol. 372, 121203, 15.02.2023.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Novel non-covalent conjugate based on graphene oxide and alkylating agent from 1,3,5-triazine class
AU - Sharoyko, Vladimir V.
AU - Semenov, Konstantin N.
AU - Mikolaichuk, Olga V.
AU - Shemchuk, Olga S.
AU - Abdelhali, Abdelsattar O. E.
AU - Potanin, Artem A.
AU - Luttsev, Michail D.
AU - Daler R. Dadajanov, null
AU - Shasherina, Anna Yu.
AU - Petrov, Andrey V.
AU - Murin, Igor V.
AU - Maystrenko, Dmitriy N.
AU - Molchanov, Oleg E.
AU - Vartanyan, T.A.
PY - 2023/2/15
Y1 - 2023/2/15
N2 - One of the ways to increase the specificity and biocompatibility of cytostatic drugs is the creation of conjugates of drugs with graphene oxide. Graphene and its oxidized form - graphene oxide (GO) - have become new promising materials in the field of nanomedicine due to its reactive and developed surface that can be subjected to covalent and non-covalent functionalization, which allows provide the immobilization of drugs. This article is devoted to a new method for the synthesis, identification and study of the biocompatibility of a non-covalent conjugate based on GO and an alkylating agent based on 1,3,5-triazine. The conjugate is hemocompatible, exhibit antioxidant activity in the model reaction with DPPH, Radachlorin and photoinduced hemolysis, has dose-dependent genotoxicity, and also exhibit cytotoxicity towards cell lines A549, PANC-1 and HeLa.
AB - One of the ways to increase the specificity and biocompatibility of cytostatic drugs is the creation of conjugates of drugs with graphene oxide. Graphene and its oxidized form - graphene oxide (GO) - have become new promising materials in the field of nanomedicine due to its reactive and developed surface that can be subjected to covalent and non-covalent functionalization, which allows provide the immobilization of drugs. This article is devoted to a new method for the synthesis, identification and study of the biocompatibility of a non-covalent conjugate based on GO and an alkylating agent based on 1,3,5-triazine. The conjugate is hemocompatible, exhibit antioxidant activity in the model reaction with DPPH, Radachlorin and photoinduced hemolysis, has dose-dependent genotoxicity, and also exhibit cytotoxicity towards cell lines A549, PANC-1 and HeLa.
KW - antioxidant activity
KW - cytotoxicity
KW - hemocompatibility
KW - graphene oxide
KW - Hemocompatibility
KW - Antioxidant activity
KW - Genotoxicity
KW - Cytotoxicity
KW - 1,3,5-triazine
KW - Graphene oxide
UR - https://www.mendeley.com/catalogue/f0b554d5-2170-3ce2-8662-fc781a90877b/
U2 - 10.1016/j.molliq.2023.121203
DO - 10.1016/j.molliq.2023.121203
M3 - Article
VL - 372
JO - Journal of Molecular Liquids
JF - Journal of Molecular Liquids
SN - 0167-7322
M1 - 121203
ER -
ID: 100670874